Items where authors include "Pang, Y."
![[up]](/style/images/multi_up.png)
Up a levelArticle
Abani, O., Abbas, A., Abbas, F. et al. (7724 more authors) (2025) Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Infectious Diseases. ISSN 1473-3099
Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642
Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642
Shao, Z., Han, J., Debattista, K. et al. (1 more author) (2024) DCMSTRD: End-to-end dense captioning via multi-scale transformer decoding. IEEE Transactions on Multimedia, 26. pp. 7581-7593. ISSN 1520-9210
Shao, Z., Han, J., Debattista, K. et al. (1 more author) (2023) Textual context-aware dense captioning with diverse words. IEEE Transactions on Multimedia, 25. pp. 8753-8766. ISSN 1520-9210
Proceedings Paper
Ren, X. orcid.org/0000-0002-6086-616X, Kong, D., Doğan, H.A. et al. (2 more authors) (2025) Digital Dong: Heritage assessment, reality capturing and 3D modelling. In: Structural Analysis of Historical Constructions: Heritage conservation in the digital era. 14th International Conference on Structural Analysis of Historical Constructions (SAHC 2025), 15-17 Sep 2025, Lausanne, Switzerland. RILEM Bookseries . Springer Cham . (In Press)
Meehan, D., Pang, Y., Fisher, P. et al. (8 more authors) (2023) 85 - Outcomes of patients in South Yorkshire with PDL-1 positive or negative locally advanced or metastatic squamous (NSCLC) treated with first line pembrolizumab in combination with carboplatin and paclitaxel. In: Lung Cancer. 21st Annual British Thoracic Oncology Group Conference 2023, 26-28 Apr 2023, Belfast, Northern Ireland. Elsevier , S37-S37.